Key Events This Week
10 Aug: New 52-week and all-time high at Rs.1,052.30 with upper circuit hit
11 Aug: Further surge to Rs.1,159.20, hitting new 52-week and all-time highs with upper circuit
12 Aug: Minor correction with slight price dip amid lower volumes
13 Aug: Continued consolidation with marginal decline
14 Aug: Small recovery to close at Rs.1,107.50
10 August 2026: Breakout to New Highs with Upper Circuit Surge
Sudeep Pharma Ltd began the week with a remarkable rally, opening at Rs.1,053.85, up 10.00% from the previous close. The stock surged intraday to a new 52-week and all-time high of Rs.1,052.30, hitting the upper circuit limit with a maximum gain of 9.65%. This strong price action was accompanied by a significant volume spike of 5.49 lakh shares and a turnover of ₹56.24 crore, signalling intense buying interest.
The stock outperformed the Pharmaceuticals & Biotechnology sector by nearly 10 percentage points and the Sensex by over 9.9%, which closed marginally higher by 0.09%. Technical indicators were strongly bullish, with the stock trading above all key moving averages and supported by positive MACD and Bollinger Bands signals. However, delivery volumes showed a decline, suggesting some short-term speculative trading rather than sustained accumulation.
The regulatory freeze triggered by the upper circuit hit reflected unfilled demand, indicating latent buying pressure that could influence future price movements.
11 August 2026: Continued Momentum with New 52-Week High and Upper Circuit
The bullish momentum extended into 11 August, with Sudeep Pharma Ltd reaching an intraday peak of Rs.1,159.20, a fresh 52-week and all-time high. The stock closed at Rs.1,129.00, up 7.19% on the day, again hitting the upper circuit limit amid robust buying pressure. Trading volumes remained elevated at approximately 5.49 lakh shares, with delivery volumes increasing by 60.4% compared to the five-day average, indicating stronger investor conviction.
Despite a broadly negative market day where the Sensex declined 0.42%, Sudeep Pharma outperformed its sector by over 6 percentage points. Technical positioning remained strong with the stock comfortably above all major moving averages and supported by bullish weekly MACD and Bollinger Bands. The Mojo Score of 58.0 and a Hold grade reflect a balanced view of the stock’s fundamentals amid this rally.
Intraday volatility was high, with a weighted average price volatility of 25.48%, underscoring active trading and dynamic market participation.
Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.
- - Investment Committee approved
- - 50+ candidates screened
- - Strong post-announcement performance
12 August 2026: Minor Correction Amid Lower Volumes
Following two days of strong gains, Sudeep Pharma Ltd experienced a slight pullback on 12 August, closing at Rs.1,105.35, down 0.39%. The stock traded on lower volumes of 17,111 shares, reflecting a pause in the intense buying momentum. The Sensex also declined by 0.17%, indicating a cautious market environment.
Technical indicators remained largely positive but showed signs of consolidation. The stock stayed above key moving averages, maintaining its overall bullish trend despite the minor correction. Delivery volumes were subdued, suggesting reduced investor participation on this day.
13 August 2026: Continued Consolidation with Marginal Decline
Sudeep Pharma Ltd continued to consolidate on 13 August, closing at Rs.1,101.25, down 0.37%. Trading volumes further declined to 14,251 shares. The Sensex rebounded slightly, gaining 0.16%, but the stock lagged marginally amid mixed market signals.
The stock remained technically supported above its moving averages, with no significant change in momentum. The consolidation phase may reflect investors digesting the sharp gains from earlier in the week.
14 August 2026: Small Recovery to Close the Week
On the final trading day of the week, Sudeep Pharma Ltd recovered modestly, closing at Rs.1,107.50, up 0.57% on low volumes of 6,135 shares. The Sensex declined 0.17%, ending the week on a cautious note. The stock’s slight rebound suggests some renewed buying interest after the consolidation phase.
Technical indicators remain supportive, with the stock maintaining its position above key moving averages and a Mojo Grade of Hold, reflecting a balanced outlook amid recent volatility.
Is Sudeep Pharma Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Daily Price Comparison: Sudeep Pharma Ltd vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-08-10 | Rs.1,053.85 | +10.00% | 37,131.97 | +0.09% |
| 2026-08-11 | Rs.1,109.65 | +5.29% | 37,029.82 | -0.28% |
| 2026-08-12 | Rs.1,105.35 | -0.39% | 36,967.15 | -0.17% |
| 2026-08-13 | Rs.1,101.25 | -0.37% | 37,024.45 | +0.16% |
| 2026-08-14 | Rs.1,107.50 | +0.57% | 36,962.93 | -0.17% |
Key Takeaways from the Week
Strong Price Momentum: Sudeep Pharma Ltd demonstrated robust price appreciation, gaining 15.60% over the week, significantly outperforming the Sensex’s 0.37% decline. The stock’s ability to hit multiple new 52-week and all-time highs early in the week highlights strong investor demand and positive sentiment.
Technical Strength: The stock consistently traded above all major moving averages, supported by bullish MACD and Bollinger Bands signals. The upper circuit hits on 10 and 11 August reflect intense buying pressure and technical breakout confirmation.
Volume and Liquidity: Elevated trading volumes and turnover on the first two days contrasted with lower volumes and delivery participation later in the week, indicating a shift from aggressive buying to consolidation and profit-taking.
Market Context: The broader market showed mixed to negative trends, with the Sensex declining marginally. Sudeep Pharma’s outperformance amid this environment underscores its relative strength within the Pharmaceuticals & Biotechnology sector.
Valuation and Rating: The stock’s Mojo Score of 58.0 and Hold grade reflect a balanced view of its fundamentals and technicals, suggesting cautious optimism amid elevated valuations and recent volatility.
Conclusion
Sudeep Pharma Ltd’s performance during the week of 10-14 August 2026 was marked by a powerful rally that propelled the stock to new highs, supported by strong technical indicators and robust trading volumes. The early week surge, including two upper circuit hits, demonstrated significant investor enthusiasm and momentum. However, the latter part of the week saw consolidation and modest corrections amid lower volumes, reflecting a natural pause after rapid gains.
The stock’s substantial outperformance relative to the Sensex and its sector highlights its current market prominence. While the Mojo Grade of Hold advises measured optimism, the company’s solid financial metrics and technical strength provide a foundation for sustained interest. Investors should monitor volume trends and broader market conditions closely as the stock navigates this phase of heightened activity and price discovery.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
